November 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
According to market projections, the theranostics sector is expected to grow from USD 2.42 billion in 2024 to USD 10.21 billion by 2034, reflecting a CAGR of 15.46%. Technological advancements and boosting non-oncological applications are driving the global market expansion. North America led with its rising cancer cases and healthcare system....
November 01, 2025
Market insights predict, the infectious disease diagnostics industry is expected to grow from USD 25.01 billion in 2024 to USD 62.95 billion by 2034, driven by a CAGR of 9.67%.The market is growing due to healthcare providers seeking faster, more reliable detection methods to control outbreaks. Growing awareness, government initiatives, and technol...
November 01, 2025
Based on market forecasts, the point-of-care molecular diagnostics sector will expand from USD 4.05 billion in 2024 to USD 11.03 billion by 2034, experiencing a CAGR of 10.45%. The point-of-care molecular diagnostics market is expanding due to increasing decentralized healthcare as well as growing advancements in multiplex tests. North America le...
November 01, 2025
According to market projections, the global DNA test kits market, valued at USD 1.61 billion in 2024, is anticipated to reach USD 7.78 billion by 2034, growing at a CAGR of 17.04% over the next decade. The growing demand for early diagnosis and point-of-care diagnostics drives the market. North America dominated the global market owing to the prese...
November 01, 2025
According to forecasts, the global endocrine testing market will grow from USD 2.99 billion in 2024 to USD 6.75 billion by 2034, with an expected CAGR of 8.54%. With more individuals proactively monitoring their health, the endocrine testing market is seeing a growing interest in personalized medicine and home-based testing kits. North America led ...
November 01, 2025
According to market projections, the global allergy diagnostics market, valued at USD 5.79 billion in 2024, is anticipated to reach USD 16.45 billion by 2034, growing at a CAGR of 10.96% over the next decade. The rising incidence of allergies and technological advancements bolster market growth. North America dominated the global market due to the ...
November 01, 2025
Based on market forecasts, the global syphilis testing market, projected at USD 2.29 billion in 2024, is expected to reach USD 4.57 billion by 2034, growing at a CAGR of 6.85% over the forecast period. The market is expanding due to the global increase in syphilis cases and other sexually transmitted infections. Growth is further fueled by rising a...
November 01, 2025
Projections indicate that, the global preimplantation genetics diagnosis (PGD) market will increase from USD 67.79 million in 2024 to USD 144.19 million by 2034, experiencing a CAGR of 7.84% over the next 10 years. The preimplantation genetics diagnosis (PGD) market is expanding due to growing advancements as well as increasing IVF usage. North Ame...
November 01, 2025
According to market projections, the immunoassay sector is expected to grow from USD 35.61 billion in 2024 to USD 56.54 billion by 2034, reflecting a CAGR of 4.72%. Ongoing technological advances are propelling the global market growth. North America dominated the market due to a rise in demand for precision diagnostics, treatment, and R&D inve...
November 01, 2025
Projections indicate that, point-of-care infectious disease testing industry is projected to rise from USD 11.9 billion in 2024 to USD 17.75 billion by 2034, reflecting a CAGR of 4.34% over the next decade. The point-of-care infectious disease testing market is expanding due to patient-centric care as well as increasing lateral flow test innovation...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com